Vivli’s Post

Many thanks to Daniel Levine for a great conversation on The Bio Report podcast about the many ways that #realworlddata can support evidence generation to benefit cancer patients, in particular recent approaches to enhancing trial representativeness by applying RWD to study design, and reducing patient and site burden by streamlining data collection needs. The closer we can integrate #clinicaltrials into routine care, the more likely that study results will be generalizable to ALL cancer patients.

The value of #RWD for informing better trial designs, supporting regulatory decisions, and improving patient diversity is critical as we continue to close the gap between care and research. Neal Meropol, Flatiron's Head of Research Oncology, was recently interviewed on The Bio Report with Daniel Levine to explain how #realworlddata from the EHR is transforming cancer #clinicaltrials and drug development. Tune in to learn how Flatiron Health is harnessing the power of RWD to reshape the landscape of oncology research and accelerate the development of new treatments. ▶️ https://lnkd.in/g7YvHNK3

Learn now to access Integra Connect’s sample database in #SnowMarketplace to feature basic population-level statistics and visualizations that practices, payers and life science companies would use to assess a population of patients. https://okt.to/zSLpyM

In Hungary, lung cancer is the leading cause of cancer death. While, since early 2022, molecular testing has been covered across the country, awareness about #precisionmedicine is still limited among healthcare professionals and patients. 🇭🇺The Hungary Country Pilot, a multi-stakeholder program led by Lélek-Zet to improve patient awareness of biomarker testing among patients with adapted materials, used the adaptable tool 𝗔𝗰𝗰𝗲𝘀𝘀 𝗕𝗮𝗿𝗿𝗶𝗲𝗿 𝗖𝗮𝘂𝘀𝗲-𝗘𝗳𝗳𝗲𝗰𝘁 𝗖𝗮𝗻𝘃𝗮𝘀 to map patients' needs. This resource is like a 𝗰𝗹𝗲𝗮𝗿 𝗽𝗶𝗰𝘁𝘂𝗿𝗲 of what patients experience, highlighting any roadblocks to accessing precision medicine. 👉 You can use it too! The tool is available for adaptation in your own practice or community: https://lnkd.in/dkp8K5iw

On this #ClinicalTrialsDay, we commemorate Dr. James Lind's pioneering work on May 20, 1747, when he conducted the first-ever randomized controlled trial. Despite this milestone, we still have a long way to go in educating people about the importance and impact of clinical trials. #ClinicalResearch #HealthcareInnovation https://lnkd.in/givtHTTB #AYACSM #Tylenolstartedhere

We are excited to share a new video we developed alongside A Cure In Sight™ and Dr. Richard Carvajal on the importance of Uveal Melanoma patient registries and how they drive research forward. Click the link below to hear about the latest trends in uveal melanoma research and the role patient registries are playing! #bettertogether #uvealmelanoma #realworlddata

Want to see some #OHDSI OMOP Common Data Model in action? Check this out.

With major advances in the understanding of cancer, the cancer treatment landscape has evolved, resulting in significant changes in therapy and in turn the primary endpoints elected for cancer clinical trials. Experts emphasize the need for transparency when changing primary endpoints in oncology clinical trials.

📰In a recent Editorial representing the EHA Board, authors delve into the history, updates, and challenges surrounding the current World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues. While divergences within academic medical communities foster innovation, they also present challenges for hematology practitioners across different settings. The EHA board highlights significant differences, with 2 included papers, between the new classifications and the WHO 2017 blue book, with the overarching goal of optimizing and standardizing the diagnosis and monitoring of these cancers. Read more here 👉https://bit.ly/4anrJm9 #EHA #WHO #openaccess

Elevate your market insights with PIVOT reports and bridge the gap between clinical practice and market strategy. Engage digitally with community oncologists, understand clinical practice trends, and align your strategy with the latest in #CancerCare. https://lnkd.in/dXAvsFBF